Top news of the week: 12.05.2020.
#startups #genetherapy #XceleratingLS #XconSF #BIO2020
Startups
Fueled by $500 million in federal cash, Moderna races to make 1 billion doses of an unproven cure
https://t.co/v4dl9m9VP5 By @leah_rosenbaum https://t.co/LF7BAE2EZh
OpenFueled By $500 Million In Federal Cash, Moderna Races To Make A Billion Doses Of An Unproven Cure
The company’s billionaire CEO has secured huge grants on the promise of a new class of mRNA vaccines, but nobody really knows if they will work.
RT @BentheFidler: Dyno spins out of Harvard's laboratories with an aim to make gene therapy better https://t.co/LKO5HcbQEf @byJonGardner #genetherapy #startups $SRPT $NVS
OpenDyno spins out of Harvard's laboratories with an aim to make gene therapy better
The startup announced collaborations with Novartis and Sarepta, both leading gene therapy makers, that could be worth $2 billion in total.
RT @Xconomy: We'd like to welcome @charleskfisher, @unlearnai founder & CEO, to our Xcelerating Life Sciences San Francisco: The AI, Big Data, and R&D Boom speaker lineup! Join us online June 25:
https://t.co/lbNTq9XNDQ #XconSF #XceleratingLS https://t.co/5whduMx51p
OpenXcelerating Life Sciences San Francisco: An online biotech conference & networking event focused on the AI, big data, and R&D boom
Scientists, entrepreneurs, and biotech executives discuss the boom in AI, big data, and R&D in the Bay Area, along with roadblocks.
Can the U.S. learn from Italy, where antibody test makers are fighting for a new market?
https://t.co/Fkbbephjsn By @giacomotognini https://t.co/kfP4mdl7Hp
OpenCan The U.S. Learn From Italy, Where Antibody Test Makers Are Fighting For A New Market?
In a bid to reopen their economies, Italy’s 20 regions are buying hundreds of thousands of antibody tests. Amid the chaos, the world’s top test makers are battling it out for control of a ...
Months after closing $617M life sciences fund, Frazier Healthcare nabs biopharma vets https://t.co/AJfANM1vUi https://t.co/EWfhv2XOip
OpenMonths after closing $617M life sciences fund, Frazier Healthcare nabs biopharma vets
Venture capital firm Frazier Healthcare has grabbed Scott Byrd, Ian Mills, and Gordon McMurray as its new Entrepreneur-in-Residence consultants.
.@VentusGNS Launches With $60M to Shine Light on Innate Immune System Drugs
- by @frankvinluan
https://t.co/hOyky7FgSJ
$NVS
OpenVentus Launches With $60M to Shine Light on Innate Immune System Drugs
The innate immune system has become a hot area for drug development, and for good reason. As the body’s first line of defense, its function (or
UK tech founders warn of 'significant' job losses and say they can't access a $300 million rescue fund over a technicality https://t.co/DKlUt7wB1O
OpenUK tech founders warn of 'significant' job losses and say they can't access a $300 million rescue fund over a technicality
Startups might collapse thanks to a technicality that would deny them rescue funding.
RT @BritSab09: We’ve got your roadmap for navigating a virtual #BIO2020. Don’t miss these best practices for connecting virtually on 5/20 via webinar https://t.co/SQcko4KGk0 @JLABS @CALifeSciences @BiocomCA @BIOConvention https://t.co/vAKtopoOsz
OpenPrepping for a Digital BIO 2020
This year’s BIO International Convention is unlike any other - are you ready to make the most of connecting virtually with potential partners, investors and industry peers? As an ...